Literature DB >> 18448482

Age-dependent inhibition of ectopic calcification: a possible role for fetuin-A and osteopontin in patients with juvenile dermatomyositis with calcinosis.

G Marhaug1, V Shah, R Shroff, H Varsani, L R Wedderburn, C A Pilkington, P A Brogan.   

Abstract

OBJECTIVES: To assess if age and/or age-dependent variations in the levels of two major calcification regulatory proteins, fetuin-A and osteopontin, could be associated with an increased risk of calcinosis in children with juvenile dermatomyositis (JDM).
METHODS: The frequency of calcinosis was derived from a national UK database of 212 cases of JDM. Serum fetuin-A and plasma osteopontin levels were determined using ELISA in 15 JDM patients with calcinosis and 15 JDM patients without calcinosis. Healthy controls were 19 age-matched children, 24 adolescents and 13 adults. Sixteen patients with juvenile idiopathic arthritis (JIA) were additional paediatric disease controls.
RESULTS: Of the 212 JDM cases 10% had calcinosis. Calcinosis patients had younger age of disease onset than those without calcinosis (mean age of 5.3 yrs vs 7.1 yrs, respectively, P = 0.016). No significant difference in fetuin-A or osteopontin could be detected between the two JDM groups. Fetuin-A levels in all groups of children and the adolescent group were much lower than described previously in adults, and there was a significant positive correlation between age and fetuin-A level, and also between osteopontin levels in plasma and serum fetuin-A.
CONCLUSIONS: Children who develop JDM at an younger age may have increased risk of developing calcinosis. Physiologically low levels of fetuin-A in young children combined with an additional negative acute-phase effect on fetuin-A due to chronic inflammation could explain in part the propensity to develop ectopic calcification observed in JDM patients, and why calcinosis is less frequent in adults with dermatomyositis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18448482     DOI: 10.1093/rheumatology/ken136

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  16 in total

Review 1.  The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis.

Authors:  Mark F Hoeltzel; Edward J Oberle; Angela Byun Robinson; Arunima Agarwal; Lisa G Rider
Journal:  Curr Rheumatol Rep       Date:  2014-12       Impact factor: 4.592

2.  Evaluation of Serum Fetuin-A and Osteoprotegerin Levels in Patients with Psoriasis.

Authors:  Mehmet Genc; Murat Can; Berrak Guven; Saniye Cinar; Cagatay Buyukuysal; Bilgehan Acikgoz; Ayca Gorkem Mungan; Serefden Acikgoz
Journal:  Indian J Clin Biochem       Date:  2016-05-06

3.  SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy.

Authors:  E Pegoraro; E P Hoffman; L Piva; B F Gavassini; S Cagnin; M Ermani; L Bello; G Soraru; B Pacchioni; M D Bonifati; G Lanfranchi; C Angelini; A Kesari; I Lee; H Gordish-Dressman; J M Devaney; C M McDonald
Journal:  Neurology       Date:  2010-12-22       Impact factor: 9.910

Review 4.  Subcutaneous calcinosis: Is it different between systemic sclerosis and dermatomyositis?

Authors:  Antonia Valenzuela; Lorinda Chung
Journal:  J Scleroderma Relat Disord       Date:  2021-10-28

5.  A national registry for juvenile dermatomyositis and other paediatric idiopathic inflammatory myopathies: 10 years' experience; the Juvenile Dermatomyositis National (UK and Ireland) Cohort Biomarker Study and Repository for Idiopathic Inflammatory Myopathies.

Authors:  Neil Martin; Petra Krol; Sally Smith; Kevin Murray; Clarissa A Pilkington; Joyce E Davidson; Lucy R Wedderburn
Journal:  Rheumatology (Oxford)       Date:  2010-09-07       Impact factor: 7.580

6.  Juvenile dermatomyositis calcifications selectively displayed markers of bone formation.

Authors:  Annette L Urganus; Yong-Dong Zhao; Lauren M Pachman
Journal:  Arthritis Rheum       Date:  2009-04-15

Review 7.  Calcinosis Biomarkers in Adult and Juvenile Dermatomyositis.

Authors:  Melody P Chung; Carrie Richardson; David Kirakossian; Amir B Orandi; Lesley A Saketkoo; Lisa G Rider; Adam Schiffenbauer; Carlos A von Mühlen; Lorinda Chung
Journal:  Autoimmun Rev       Date:  2020-03-28       Impact factor: 9.754

8.  Comparison of children with onset of juvenile dermatomyositis symptoms before or after their fifth birthday in a UK and Ireland juvenile dermatomyositis cohort study.

Authors:  N Martin; P Krol; S Smith; L Beard; C A Pilkington; J Davidson; L R Wedderburn
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-11       Impact factor: 4.794

9.  The Immunohistochemical Patterns of Calcification-related Molecules in the Epidermis and Dermis of the Zebrafish (Danio rerio).

Authors:  Yeon Ju Hong; You Won Choi; Ki Bum Myung; Hae Young Choi
Journal:  Ann Dermatol       Date:  2011-08-06       Impact factor: 1.444

10.  Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosus.

Authors:  Ornella J Rullo; Jennifer M P Woo; Miriam F Parsa; Alice D C Hoftman; Paul Maranian; David A Elashoff; Timothy B Niewold; Jennifer M Grossman; Bevra H Hahn; Maureen McMahon; Deborah K McCurdy; Betty P Tsao
Journal:  Arthritis Res Ther       Date:  2013-01-23       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.